LAWRENCE, Mass. (AP) -- Medical device maker NxStage Medical Inc. said Tuesday its first-quarter loss narrowed as revenue climbed on growing adoption of its NxStage System One home kidney dialysis ...

NxStage Medical (NASDAQ: NXTM) has revolutionized the way that dialysis patients receive treatment, with its home-dialysis devices offering a much more convenient alternative to visiting outpatient ...

Please provide your email address to receive an email when new articles are posted on . NxStage Medical Inc.’s next generation System One hemodialysis system has received the CE mark in Europe. The ...

NxStage Medical, a medical technology outfit focused on advancing renal care, has received clearance from the FDA for its System One, which allows for solo home hemodialysis, without a care partner, ...

LAWRENCE, Mass., Aug. 4, 2017 /PRNewswire/ -- NxStage Medical, Inc. (Nasdaq: NXTM), a leading medical technology company focused on advancing renal care, joins over one hundred NxStage patients in ...

Massachusetts-based manufacturer of innovative dialysis products, NxStage Medical, Inc.NXTM, will present four new abstracts demonstrating clinical results during the National Kidney Foundation's ...

NxStage Medical, Inc.NXTM recently announced the regulatory approval of its System One platform by the FDA for solo home hemodialysis treatment. The company has also announced that it will provide ...